Bryant Ranch Prepack

Bryant Ranch Prepack Inc. is a for-profit pharmaceutical manufacturer based in Burbank, California, that specializes in the production and supply of pharmaceutical tablets and injectable medications to federal healthcare agencies. The company has established itself as a reliable supplier to the Department of Veterans Affairs and other federal health systems, leveraging its manufacturing capabilities to serve the procurement needs of government healthcare operations. Registered in SAM.gov since November 2017, Bryant Ranch Prepack operates as a small business and has developed a substantial track record of federal contracting experience.

Bryant Ranch Prepack's recent federal contract awards demonstrate its core competency in supplying specialized pharmaceutical preparations to the Veterans Integrated Service Network 15 (VISN 15). The company has received multiple small business set-aside purchase orders from the Department of Veterans Affairs for the supply of critical medications including Acetaminophen/Butalbital/Caffeine combination tablets, Sevelamer Carbonate 800mg tablets, and Sumatriptan 6mg/0.5mL injection syringes. These awards, valued between approximately $28,000 and $97,000, support the VA's Consolidated Mail Outpatient Pharmacy (CMOP) network, which distributes medications across six regional facilities serving veterans nationwide. All of Bryant Ranch Prepack's recent purchase order awards have been designated as Total Small Business Set-Asides, reflecting the company's qualification under federal small business contracting programs. The contracts specify strict compliance requirements including adherence to the Drug Supply Chain Security Act and state wholesale distributor licensing regulations, underscoring the regulatory demands of pharmaceutical supply to federal agencies.

Bryant Ranch Prepack currently holds two significant Indefinite Delivery Contracts awarded by the VA National Acquisition Center, representing a combined ceiling value of $17.7 million. The first IDC, awarded on September 23, 2025, carries a ceiling value of $14,563,769.10 for the supply of Hydroxychloroquine SO4 tablets in 100-tablet and 500-tablet package configurations, with a base performance period of one year and four one-year option periods extending through September 22, 2026. The second IDC, originally awarded on September 17, 2024, with a ceiling value of $3,175,362.90, covers the supply of Digoxin tablets in multiple strengths (0.125mg and 0.25mg) and package sizes (100-count and 1,000-count bottles), with performance extending through September 16, 2026, including the exercise of the first option year. Both unrestricted contracts support multiple federal healthcare entities including the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with distribution occurring through the VA and DoD Pharmaceutical Prime Vendor Programs. These IDVs position Bryant Ranch Prepack as an established supplier of maintenance medications and chronic disease management pharmaceuticals to the federal government's healthcare systems.